Serina Therapeutics (SER) Net Income by Year
Serina Therapeutics reported a net loss of $19.2M in fiscal year 2025. This represents a decrease of 72.2% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Serina Therapeutics has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SER Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
SER Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Serina Therapeutics financials
Frequently Asked Questions
What was Serina Therapeutics's net income in fiscal year 2025?
Serina Therapeutics reported a net loss of $19.2M in fiscal year 2025.
How fast is Serina Therapeutics's net income growing?
Serina Therapeutics (SER) net income fell by 72.2% year over year, from -$11.1M to -$19.2M in fiscal year 2025.
How has Serina Therapeutics's net income changed over the years?
Across the 9 fiscal years this page covers, Serina Therapeutics (SER) net income went from -$6.6M in fiscal year 2017 to -$19.2M in fiscal year 2025.
What was Serina Therapeutics's net income in the most recent quarter?
Serina Therapeutics (SER) reported -$6.4M in net income in Q2 2026. This represents an increase of 1.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Serina Therapeutics (SER) reported on that line in every period on record.